Ghent University and MDxHealth Collaborate to Establish a Center in Pharmaco (Epi)genomics
MDxHealth SA announced that it has joined forces with the Ghent University to establish NXTGNT, a new Center in Pharmaco (Epi)genomics.
The mission of the Center is to accelerate innovation in personalized medicine by using advanced technology, knowledge and expertise in (epi)genetics. The Center will bring together scientific expertise from disease centered basic researchers, corresponding clinical validation teams, bioinformaticians, and cutting edge (epi)genomic technology focused on the discovery of effective individualized epigenetic-based diagnostic and personalized therapeutic products.
As a result of several years of productive collaboration between the Laboratory of Bioinformatics and Computational Genomics (BIOBIX), NXTGNT (UGent genome analysis facility), the Biomarked valorization consortium teams and MDxHealth, the new Center is located at Ghent University within the laboratory of Pharmaceutical Biotechnology. The facility will house MDxHealth's research team and lab equipment for development of epigenetic tests together with the Ghent University team for (epi)genetic sequencing. The facility works in close collaboration with the Laboratory of Bioinformatics and Computational Genomics, located at the Faculty of BioEngeneering, providing extensive expertise in epigenetic characterization and computing and visualization of (epi)genomic datasets. The Center is fully operational as off December 1, 2012.
Other news from the department science
